These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10823705)

  • 1. Sustained-release phenylpropanolamine hydrochloride bilayer caplets containing the hydroxypropylmethylcellulose 2208 matrix. I. Formulation and dissolution characteristics.
    Ohmori S; Makino T
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):673-7. PubMed ID: 10823705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained-release phenylpropanolamine hydrochloride bilayer caplets containing the hydroxypropylmethylcellulose 2208 matrix. II. Effects of filling order in bilayer compression and manufacturing method of the prolonged-release layer on compactibility of bilayer caplets.
    Ohmori S; Makino T
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):678-82. PubMed ID: 10823706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release dosage form of phenylpropanolamine hydrochloride (3). Application of factorial design.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(4):439-44. PubMed ID: 7931943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix polymeric excipients: comparing a novel interpolyelectrolyte complex with hydroxypropylmethylcellulose.
    Lu Z; Chen W; Olivier E; Hamman JH
    Drug Deliv; 2008 Feb; 15(2):87-96. PubMed ID: 18293194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):327-34. PubMed ID: 8064556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
    Chen L; Wang F
    Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
    Gohel M; Bariya SH
    Pharm Dev Technol; 2009; 14(6):650-8. PubMed ID: 19883254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
    Yadav K; Yadav D; Srivastava AK
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1197-206. PubMed ID: 22803761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melt Extrusion for a High Melting Point Compound with Improved Solubility and Sustained Release.
    Lu J; Obara S; Liu F; Fu W; Zhang W; Kikuchi S
    AAPS PharmSciTech; 2018 Jan; 19(1):358-370. PubMed ID: 28741140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melt granulation and heat treatment for wax matrix-controlled drug release.
    Zhang YE; Schwartz JB
    Drug Dev Ind Pharm; 2003 Feb; 29(2):131-8. PubMed ID: 12648009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules IV.(1)) Evaluation of the controlled release properties for in vivo and in vitro release systems.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1569-73. PubMed ID: 17978513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-dis and the paddle dissolution apparatuses applied to the release characterization of ketoprofen from hypromellose matrices.
    Ramos Pezzini B; Gomes Ferraz H
    AAPS PharmSciTech; 2009; 10(3):763-71. PubMed ID: 19495988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of multiunit controlled-release phenylpropanolamine hydrochloride tablets.
    Mitrevej A; Sinchaipanid N; Natpoolwat N; Naratikornrit N
    Drug Dev Ind Pharm; 1998 Aug; 24(8):793-6. PubMed ID: 9876528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation.
    Nirmal J; Saisivam S; Peddanna C; Muralidharan S; Godwinkumar S; Nagarajan M
    Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1455-8. PubMed ID: 18827389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.